EUVIMEDEUVIMED entdecken
Crossref

Thiolated Chitosan Based Mucoadhesive Lipid Nanoparticles for Enhanced Solubility and Sustained Release of Aprepitant

Mazhar Hussain, Muhammad Asad Saeed, Muhammad Ijaz, Muhammad Zaman, Sherjeel Adnan, Zeeshan Masood, Nabeela Ameer, Muhammad Waqas, Hafiz Muhammad Abdur Rahman, Muhammad Farooq

ChemistrySelect · 2026-03 · 11 (12)

DOI: 10.1002/slct.202502703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 24.03.2026. Verfasst von Mazhar Hussain und 9 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aimed to develop an Aprepitant (APT)‐loaded controlled‐release solid‐lipid nanoparticles (SLN) using a precipitation method with chitosan and thiolated chitosan (TC) to enhance drug solubility and mucoadhesion. The optimized SLN formulation (APT‐TCF4) showed a particle size of 87.28 ± 0.43 nm, a zeta potential of +13.8 ± 0.54, encapsulation efficiency of 93.92 ± 0.87%, and 71.25 ± 0.64% solubility of APT in phosphate buffer (pH 6.8). Scanning electron microscopy (SEM) revealed nanosized, amorphous spherical particles and FTIR analysis confirmed good compatibility between APT and the polymers (chitosan and TC) while, physicochemical evaluation indicated no drug‐polymer interactions. In vitro drug release study demonstrated that APT‐TCF4 exhibited controlled drug release (84.56 ± 0.46%) over 12 h in phosphate buffer (pH 6.8), following the Higuchi release model. Additionally, APT‐TCF4 showed a 26‐fold increase in mucoadhesion compared to APT alone and an 11‐fold increase compared to APT‐CF4. SLN containing TC demonstrated prolonged residence time at intestinal mucosa and reduced toxicity to Caco‐2 cells. In vivo studies demonstrated a significant enhancement in APT bioavailability due to controlled swelling, increased residence time, sustained release and paracellular transportation across the intestine. Conclusively, APT‐TCF4 represents an oral drug delivery system utilizing TC to improve bioavailability and enhance mucoadhesion making it promising approach for the treatment of chemotherapy‐induced nausea and vomiting.

Zitieren

APA

Hussain, M., Saeed, M. A., Ijaz, M., Zaman, M., Adnan, S., Masood, Z., Ameer, N., Waqas, M., Rahman, H. M. A., & Farooq, M. (2026). Thiolated Chitosan Based Mucoadhesive Lipid Nanoparticles for Enhanced Solubility and Sustained Release of Aprepitant. ChemistrySelect, 11(12). https://doi.org/10.1002/slct.202502703

Vancouver

Hussain M, Saeed MA, Ijaz M, Zaman M, Adnan S, Masood Z, et al. Thiolated Chitosan Based Mucoadhesive Lipid Nanoparticles for Enhanced Solubility and Sustained Release of Aprepitant. ChemistrySelect. 2026;11(12). doi:10.1002/slct.202502703

BibTeX
@article{Hussain2026,
  author = {Hussain, Mazhar and Saeed, Muhammad Asad and Ijaz, Muhammad and Zaman, Muhammad and Adnan, Sherjeel and Masood, Zeeshan and Ameer, Nabeela and Waqas, Muhammad and Rahman, Hafiz Muhammad Abdur and Farooq, Muhammad},
  title = {Thiolated Chitosan Based Mucoadhesive Lipid Nanoparticles for Enhanced Solubility and Sustained Release of Aprepitant},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {12},
  doi = {10.1002/slct.202502703}
}
Kostenlos starten →